99-5030. Agency Information Collection Activities; Announcement of OMB Approval; Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products  

  • [Federal Register Volume 64, Number 40 (Tuesday, March 2, 1999)]
    [Notices]
    [Pages 10155-10156]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-5030]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 97N-484R]
    
    
    Agency Information Collection Activities; Announcement of OMB 
    Approval; Establishment Registration and Listing for Manufacturers of 
    Human Cellular and Tissue-Based Products
    
    AGENCY:  Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY:  The Food and Drug Administration (FDA) is announcing that a 
    collection of information entitled ``Establishment Registration and 
    Listing for Manufacturers of Human Cellular and Tissue-Based Products'' 
    has been approved by the Office of Management and Budget (OMB) under 
    the Paperwork Reduction Act of 1995.
    
    FOR FURTHER INFORMATION CONTACT:  JonnaLynn P. Capezzuto, Office of 
    Information Resources Management (HFA-250), Food and Drug 
    Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.
    
    SUPPLEMENTARY INFORMATION:  In the Federal Register of May 14, 1998 (63 
    FR 26744), the agency announced that the proposed information 
    collection had been submitted to OMB for review and clearance under 44 
    U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
    required to respond to, a collection of information unless it displays 
    a currently valid OMB control number. OMB has now approved the 
    information collection and has assigned OMB control number 0910-0372. 
    The approval expires on July 31, 2001. A
    
    [[Page 10156]]
    
    copy of the supporting statement for this information collection is 
    available on the Internet at ``http://www.fda.gov/ohrms/dockets''.
    
        Dated: February 23, 1999.
     William K. Hubbard,
     Acting Deputy Commissioner for Policy.
    [FR Doc. 99-5030 Filed 3-1-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
03/02/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-5030
Pages:
10155-10156 (2 pages)
Docket Numbers:
Docket No. 97N-484R
PDF File:
99-5030.pdf